📰 Looking Statements News
Page 37 - Looking Statements News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Looking Statements. Real-time updates on events, politics, business and more.
April 19, 2024
BOSTON, MA / ACCESSWIRE / April 19, 2024 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) today announced that its Board of Directors has approved a 1-for-80 reverse stock split of the Companys
April 18, 2024
Charlestown, St. Kitts & Nevis, April 18, 2024 (GLOBE NEWSWIRE) -- Jake P. Noch Family Office, LLC. announces today the initiation of strategic...
April 18, 2024
Revenues of $4.4 billion Continuation of challenging environment in North America and Europe during the quarter, solid demand in Latin America and Asia-Pacific regionGross profit margin of 17.3% as...
April 18, 2024
The US Department of Health and Human Services Holds a Training Series Headlined by Loot8 on AI and Cybersecurity...
April 18, 2024
Globex Mining Enterprises Inc. is pleased to announce that it has entered into an option agreement wherein Victory Battery Metals Corp. may earn 100% interest in four Globex claim groupings in the Sept Iles region of . The claims cover the Kachiwiss... - Veroeffentlicht am 18.04.2024
April 18, 2024
ATLANTA, April 18, 2024 -- Femasys Inc. , a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and...
April 18, 2024
Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split BOSTON,MA, April 18, 2024 - Pieris Pharmaceuticals, Inc. today announced that its Board of Directors has approved...
April 18, 2024
Management is working with its auditors and legal professionals to file the audited financial statements on the St. Mega Enterprise...
April 18, 2024
Fourth-quarter net revenue of $86.1 millionFull year 2023 revenue of $334.9 millionFourth-quarter gross margin of 27.8% and Variable Marketing Margin (VMM)...
April 18, 2024
/PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and...